Growth Metrics

Health Catalyst (HCAT) Equity Ratio (2018 - 2025)

Health Catalyst's Equity Ratio history spans 8 years, with the latest figure at 0.49 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 15.0% year-over-year to 0.49; the TTM value through Dec 2025 reached 0.49, up 15.0%, while the annual FY2025 figure was 0.49, 15.0% up from the prior year.
  • Equity Ratio reached 0.49 in Q4 2025 per HCAT's latest filing, down from 0.57 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.65 in Q3 2021 to a low of 0.42 in Q1 2025.
  • Average Equity Ratio over 5 years is 0.53, with a median of 0.54 recorded in 2023.
  • The largest YoY upside for Equity Ratio was 31.29% in 2021 against a maximum downside of 28.81% in 2021.
  • A 5-year view of Equity Ratio shows it stood at 0.63 in 2021, then dropped by 9.96% to 0.56 in 2022, then decreased by 7.46% to 0.52 in 2023, then fell by 18.67% to 0.43 in 2024, then grew by 15.0% to 0.49 in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Equity Ratio are 0.49 (Q4 2025), 0.57 (Q3 2025), and 0.56 (Q2 2025).